Global Hemostats and Tissue Sealants Market 2016-2020
SKU ID :TNV-10279232 | Published Date: 09-Jun-2016 | No. of pages: 66Description
About the Hemostats and Tissue Sealants Market
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels.
Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
Technavio’s analysts forecast the global hemostats and tissue sealants market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemostats and tissue sealants market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the following products:
• Topical hemostats (active hemostats, mechanical hemostats, and flowable hemostats)
• Tissue sealants (fibrin and synthetic sealants)
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hemostats and Tissue Sealants Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Advanced Medical Solutions Group
• Baxter International
• C. R. Bard
• Cryolife
• CSL Behring
• Integra LifeSciences
• Johnson & Johnson (Ethicon)
Other prominent vendors
• B. Braun
• Cardinal Health
• Cohera Medical
• Haemacure
• HyperBranch Medical Technology
• NeoMend
• Smith & Nephew
• Teijin Pharma
• Tissuemed
• Vascular Solutions
• Vivostat
• Z-Medica
Market driver
• Focus on patient safety and quicker recovery
• For a full, detailed list, view our report
Market challenge
• Paucity of ready-to-use products
• For a full, detailed list, view our report
Market trend
• Approval of fibrin sealants as broad level hemostats
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels.
Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
Technavio’s analysts forecast the global hemostats and tissue sealants market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemostats and tissue sealants market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the following products:
• Topical hemostats (active hemostats, mechanical hemostats, and flowable hemostats)
• Tissue sealants (fibrin and synthetic sealants)
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hemostats and Tissue Sealants Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Advanced Medical Solutions Group
• Baxter International
• C. R. Bard
• Cryolife
• CSL Behring
• Integra LifeSciences
• Johnson & Johnson (Ethicon)
Other prominent vendors
• B. Braun
• Cardinal Health
• Cohera Medical
• Haemacure
• HyperBranch Medical Technology
• NeoMend
• Smith & Nephew
• Teijin Pharma
• Tissuemed
• Vascular Solutions
• Vivostat
• Z-Medica
Market driver
• Focus on patient safety and quicker recovery
• For a full, detailed list, view our report
Market challenge
• Paucity of ready-to-use products
• For a full, detailed list, view our report
Market trend
• Approval of fibrin sealants as broad level hemostats
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
TOC
Tables & Figures
Companies
- PRICE
-
$2500$4000Buy Now